Antitumormittel
Patent europeic · EP0239362 · Stritgà
Inscripziun en il register
- Numer da publicaziun
- EP0239362
- Numer da la dumonda
- EP87302525
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- Stritgà
- Scrittira da patent
- Concedì
- Annunzià
- 24-03-1987
- Publitgà
- 30-09-1987
- Concedì
- 04-12-1991
- Stritgà
- 23-03-2007
- Motiv
- Durada maximala cuntanschida
- Classas IPC
- C07D 239/88 (2006.01)C07D 401/12 (2006.01)C07D 409/12 (2006.01)A61K 31/505 (2006.01)
- Prioritad
- GB A 8607683 27.03.1986
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Certificats cumplementars da protecziun
In certificat prolunghescha la protecziun dal patent per in medicament u in product da protecziun da plantas admess en Svizra.
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 30-04-2007
Durada maximala cuntanschida
Published in +pat+ No 8 in 2007
- 30-10-1998
Adressa midada
- Owner
- Zeneca Limited, Imperial Chemical House Millbank, London SW1P 3JF, United Kingdom, National Research Development, Corporation, 101 Newington Causeway, London SE1 6BU, United Kingdom → National Research Development Corporation, 10 Fleet Place, London EC4M 7SB, United Kingdom, Zeneca Limited, 15 Stanhope Gate, London W1Y 6LN, United Kingdom
Published in PIDTJ No 20 in 1998
- 15-01-1992
Concedì
Published in PIDTJ No 1 in 1992
Partidas
Possessur
Inventur
Hughes, Leslie Richard
Macclesfield, Cheshire, GB
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.